Christine A Sorkness

Distinguished Professor of Pharmacy and Medicine (
Professor Pharmacy Practice Division
UNIVERSITY OF WISCONSIN - MADISON
United States of America

Professor Pulmonology
Biography

Christine came to the UW School of Pharmacy in 1979 after serving as a faculty member at the State University of New York-Buffalo. She is a clinical investigator with the UW Allergy, Pulmonary, and Critical Care Division, Director of Clinical Research for the Morris Institute of Respiratory Research, and Director of the Anticoagulation Clinic at the William S. Middleton Memorial Veterans Hospital. She serves as a preceptor for the ASHP-accreditated Primary Care Pharmacy Residency at Veterans Hospital, the ASHP Research and Education Foundation Antithrombotic Therapy Training Program, and elective ambulatory clerkships. Dr. Sorkness serves as co-investigator for several research protocols evaluating the efficacy, safety, and prediction of response of therapeutic agents for asthma and allergic diseases. Dr. Sorkness is an investigator with the NHLBI-funded Asthma Clinical Research Network and the Childhood Asthma Research and Education Network and the NIAID-funded Inner-City Asthma Consortium. She is the Senior Associate Director of the University of Wisconsin Institute for Clinical and Translational Research, which houses the Clinical and Translational Service Award from NIRR. Professional Interests: Co-investigator for several research protocols evaluating the efficacy and safety of therapeutic agents for asthma and allergic diseases Education: BS - State University of New York-Buffalo PharmD - State University of New York-Buffalo

Research Intrest

Professional Interests: Co-investigator for several research protocols evaluating the efficacy and safety of therapeutic agents for asthma and allergic diseases

List of Publications
Weng L, Hollenbeak CS, Mauger DT, Zeiger RS, Paul IM, Sorkness CA, Lemanske RF Jr, Martinez FD, Strunk RC, Szefler SJ, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Cost-effectiveness Analysis of Fluticasone versus Montelukast in Children with Mild-to-Moderate Persistent Asthma in the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2011 Jan; 127(1): 161-166, 166.e1. PMID: 21211651. PMC Journal - In Process
Martinez FD, Chinchilli VM, Morgan WJ, Boehmer SJ, Lemanske Jr RF, Mauger DT, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bade E, Covar RA, Friedman NJ, Guilbert TW, Heidarian-Raissy H, Kelly HW, Malka-Rais J, Mellon MH, Sorkness CA, Taussig L. Use of Beclomethasone Dipropionate as Rescue Treatment for Children with Mild Persistent Asthma (TREXA): a Randomised, Double-blind, Placebo-controlled Trial. Lancet 2011 Feb 19; 377 (9766):650-7. Epub 2011 Feb 14. PMID: 21324520. PMC Journal-In Process.
Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, Gruchalla RS, Kattan M, Teach SJ, Pongracic JA, Chmiel JF, Steinbach SF, Calatroni A, Togias A, Thompson KM, Szefler SJ, and Sorkness CA. Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children. N Engl J Med 2011 Mar 17;364(11): 1005-15. PMID: 21410369. PMC Journal-In Process.